Seeking Alpha

Horizon Pharma (HZNP +2%) says it received Notices of Allowance from the U.S. Patent and...

Horizon Pharma (HZNP +2%) says it received Notices of Allowance from the U.S. Patent and Trademark Office for two applications related to Duexis ibuprofen and famotidine tablets. Duexis is for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|